Acuta Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Acuta Capital Partners’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$866K	Buy
2025 Q1	$771K	Buy
2024 Q4	$883K	Sell
2024 Q3	$1.39M	Buy
2024 Q2	–	Sell
2024 Q1	$934K	Buy
2018 Q1	–	Hold
2017 Q4	–	Hold